手部肿胀及其他非雷诺现象症状作为系统性硬化症的首发表现:两个美国队列中的患病率与临床关联
在两个美国早期系统性硬化症(SSc)队列中,分别有44.2%(194/439,GENISOS)和31.1%(292/938,CONQUER)的患者以非雷诺现象(RP)症状为首发表现,最常见为手指/手肿胀。这些患者更常有弥漫性皮肤受累和关节挛缩,且RNA聚合酶III抗体阳性率更高。
要点
- 超过30%的SSc患者以非RP症状起病,最常见为手指/手肿胀。
- 非RP首发患者更常有弥漫性皮肤受累和关节挛缩。
- 非RP首发患者RNA聚合酶III抗体阳性率更高,手指/手肿胀即使无RP也应考虑早期SSc并检测ANA及SSc相关抗体。
核心结论
- 在两个大型美国队列中,超过30%的患者以手指/手肿胀或其他症状起病,无RP作为首发“警示信号”。
- 这些患者平均表现为更严重的皮肤和肌肉骨骼疾病,突出早期识别的重要性。
- 与该表现相关的最常见自身抗体为RNA聚合酶III。
研究设计与样本
- 研究类型为两个美国队列(GENISOS和CONQUER)的数据回顾,纳入首次非RP症状5年内的患者。
- GENISOS队列中439例患者,CONQUER队列中938例患者。
主要发现
- GENISOS队列中194/439例(44.2%)以非RP症状首发,CONQUER队列中292/938例(31.1%)以非RP症状首发。
- 非RP首发症状最常见为手指/手肿胀。
- 黑人患者较其他种族和族裔类别患者更常见RP前出现非RP症状。
- 非RP首发患者较RP首发患者在入组时更常有弥漫性皮肤受累和关节挛缩,且RNA聚合酶III抗体阳性率更高。
临床怎么用
- 作者建议:手指/手肿胀即使无RP,也应促使考虑早期SSc并检测ANA及SSc相关自身抗体(包括RNA聚合酶III)。
- 作者认为:这些结果应在早期识别SSc的工作中予以考虑。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Raynaud phenomenon (RP) is often the initial clinical manifestation of systemic sclerosis (SSc), but some patients develop other manifestations first. To help elucidate the diversity of SSc presentation in its early stages, we describe the initial clinical manifestations and antinuclear antibody (ANA) profiles of patients in two early SSc cohorts. METHODS: All patient data in the Genetics vs Environment in Scleroderma Outcomes Study (GENISOS) and Collaborative National Quality and Efficacy Registry (CONQUER) cohorts were reviewed. Both studies enrolled patients within five years of the first non-RP symptom. RESULTS: In GENISOS and CONQUER, respectively, 194 (44.2%) of 439 and 292 (31.1%) of 938 patients had a non-RP initial symptom, most commonly puffy fingers/hands. Black patients had a non-RP symptom before RP more commonly than patients in other race and ethnicity categories. Non-RP first patients were more likely than RP first patients to have diffuse cutaneous involvement and joint contractures at enrollment and had a higher prevalence of RNA polymerase III antibody positivity. CONCLUSION: In two large US cohorts, >30% of patients began to manifest SSc with puffy fingers/hands or other symptoms, without the "warning sign" of RP as their initial symptom. These patients presented with more severe skin and musculoskeletal disease on average, highlighting the importance of early recognition. The most common autoantibody associated with this presentation was RNA polymerase III. These results should be considered in efforts to recognize SSc in its earliest stages. Puffy fingers/hands, even in the absence of RP, should prompt consideration of early SSc and testing for ANA and SSc-associated autoantibodies, including RNA polymerase III.
引用
- Hanif I, Assassi S, Mayes MD, et al. Hand Swelling and Other Non-Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts. Arthritis Rheumatol. 2025. PMID: 40386907. doi:10.1002/art.43237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。